Introduction {#s1}
============

Bacterial infection with the severe complication of a systemic inflammatory host response (sepsis) is a serious condition and the most common cause of death in intensive care units at hospitals, with a global incidence that remains rising [@pone.0008039-Parrillo1], [@pone.0008039-Vincent1]. Despite this, our knowledge of the complex pathophysiology of sepsis is still is incomplete. Diagnosis of sepsis in critically ill patients is demanding because of unspecific clinical signs and imprecise traditional markers [@pone.0008039-Vincent2]. To improve current diagnostic methods for sepsis, it is therefore central to identify clinically useful biomarkers that may facilitate early and precise diagnosis [@pone.0008039-Llewelyn1], [@pone.0008039-Tang1], [@pone.0008039-Marshall1]. Biomarkers may also constitute potential targets for novel treatments of bacterial infections, severe inflammation and sepsis [@pone.0008039-Vandijck1].

Dogs are commonly used in experimental studies of sepsis as well as in safety assessment studies of pharmaceuticals since their inflammatory response is similar to humans [@pone.0008039-PolideFigueiredo1], [@pone.0008039-Higgins1]. It is also important to stress that, following the sequencing of the canine genome [@pone.0008039-LindbladToh1], dogs are currently emerging as attractive models for studying the genetic background for diseases. Bacterial uterine infection (pyometra) is a common disease that develops in 25% of all intact female dogs [@pone.0008039-Egenvall1]. The disease is characterized by mainly Gram-negative infection in combination with severe local and systemic inflammation [@pone.0008039-Hagman1]. Pyometra is lethal if left untreated and patients may develop endotoxemia, sepsis or septic shock [@pone.0008039-Brady1], [@pone.0008039-Hagman2]. The most effective treatment is acute surgical removal of the uterus and ovaries (ovariohysterectomy).

Bacterial uterine infection in dogs has many similarities with severe bacterial infections in humans. For example, infection in both species is associated with induction of local and systemic inflammation, cytokine production, an acute phase reaction, endotoxemia and induction of subsequent sepsis. Therefore, an examination of disease mechanisms involved in pyometra may provide important insights to the mechanisms operating during human bacterial infection and sepsis [@pone.0008039-Hagman3], [@pone.0008039-Martin1]. Here we used Affymetrix microarray technology to investigate the mechanisms involved in pyometra. We report that pyometra causes dramatic effects on the uterine gene expression pattern. A large number of genes associated with both innate and adaptive immune responses were upregulated, and there was also a striking upregulation of a wide array of proteases and protease inhibitors. Moreover, the uterine disease was clearly associated with downregulation of a panel of transcription factors of homeobox and zinc-finger type.

Materials and Methods {#s2}
=====================

Animals {#s2a}
-------

This research study was conducted according to national regulations (The Animal Welfare Act and Ordinance, The Swedish Ministry of Agriculture) and international guidelines (the European Convention and the European Commissions Directive 86/609/EEC on protection of animals used for experimental and other scientific purposes). The study was covered by an application approved by the Uppsala Animal Ethics Committee, Uppsala, Sweden. The dogs were privately-owned patients admitted and treated according to the routines at the University Animal Hospital, Swedish University of Agricultural Sciences, Uppsala, Sweden. Written owner consent was obtained before any dog was included.

Fifteen female dogs admitted to the University Animal Hospital, Swedish University of Agricultural Sciences, for diagnosis and subsequent surgical treatment (ovariohysterectomy, OHE) of pyometra were included in the study. The control group consisted of 6 healthy female dogs admitted for elective spay (OHE). Case history and physical examination data were noted by the veterinarian in charge on a specific form at admittance, and continued daily during the hospital stay.

Blood- and Tissue Sampling {#s2b}
--------------------------

Blood samples for analysis of haematological and serum biochemical parameters were collected from all dogs before surgery from the distal cephalic vein into either non-additive, EDTA-containing or heparinized collection tubes (Becton-Dickinson, Stockholm, Sweden), chilled on ice and centrifuged. Plasma and serum were stored at −80°C until analysis. The removed uterus was cut open and a fibre swab (Culturette; Becton Dickinson AG) was used to sample the uterine contents for bacterial culturing. Tissue biopsies were snap-frozen in liquid nitrogen and stored at −80°C. The remaining uterine tissue and the ovaries were formaldehyde-fixated and used for histopathological examination.

Blood Analyses {#s2c}
--------------

The following haematological and biochemical parameters were analysed, using routine methods: Packed cell volume (PCV, %), hemoglobin (Hb), total leukocyte count (WBC), differential count and morphological evaluation of blood smears, alanine aminotransferase (ALAT), alkaline phosphatase (AP), creatinine and urea. Serum levels of the acute phase proteins, C-reactive protein (CRP) and serum amyloid A (SAA), were analyzed in one batch with commercially available kits (Tridelta Phase™ range canine CRP ELISA assay, Tridelta™ Phase range SAA ELISA assay (Tridelta, Wicklow, Ireland)). Prostaglandin 15-keto-(13,14)-dihydro-F~2α~ metabolite (PGFM) levels were analyzed as previously described [@pone.0008039-Granstrom1]. Statistically significant (p\<0.05) differences in values between the infected and healthy dogs were determined using Student\'s *t*-tests ([Table 1](#pone-0008039-t001){ref-type="table"}).

10.1371/journal.pone.0008039.t001

###### Haematological-, biochemical-, acute phase protein- and inflammatory parameters in 15 female dogs with bacterial uterine infection (pyometra) and 6 healthy control dogs.
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                                                                                    Pyometra          Control                         
  ------------------------------------------------------------ ------------ ------------------------ --------- ---------------------- ---
  Hemoglobin (g l^−1^)                                           132--199       121±30 (57--175)        15       140±21 (111--162)     5
  EVF (10^12^ l^−1^)                                            0.38--0.57   0.34±0.08 (0.17--0.50)     15      0.39±0.06 (0.3--0.5)   5
  WBC[\*](#nt102){ref-type="table-fn"} (10^9^ l^−1^)            5.2--14.1    19.5±15.6 (2.8--59.4)      15      8.1±2.1 (6.3--11.0)    5
  BN\# (10^9^ l^−1^)                                              0--0.3       3.4±5.0 (0--13.7)        14       0.0±0.0 (0.0--0.0)    5
  SN[\*](#nt102){ref-type="table-fn"} (10^9^ l^−1^)             3.0--11.5     13.5±9.7 (2.0--35.6)      15       4.7±1.1 (3.7--6.3)    4
  EoN (10^9^ l^−1^)                                              0.1--1.2     0.57±0.7 (0.0--2.4)       15       0.4±0.4 (0.2--1.1)    5
  BaN (10^9^ l^−1^)                                               0--0.1       0.01±0.05 (0--0.2)       14       0.0±0.0 (0.0--0.0)    4
  Lymphocytes[\*](#nt102){ref-type="table-fn"} (10^9^ l^−1^)     1.4--4.8      1.4±0.9 (0.1--3.2)       15      2.2±0.8 (1.6 --3.6)    5
  Monocytes[\*](#nt102){ref-type="table-fn"} (10^9^ l^−1^)       0.2--1.4      1.6±1.9 (0.2--7.7)       15       0.4±0.2 (0.3--0.8)    5
  Creatinine (µmol l^−1^)                                        40--130       106±177 (22--747)        15         76±14 (52--89)      6
  ALAT (µkat l^−1^)                                               \<1.2        0.5±0.3 (0.3--1.3)       14       0.6±0.2 (0.4--0.9)    6
  Urea (mmol l^−1^)                                              2.5--8.5     7.4±14.0 (1.2--57.5)      15       5.2±1.3 (3.9--7.5)    6
  AP[\*](#nt102){ref-type="table-fn"} (µkat l^−1^)                \<5.0       5.1±4.3 (0.8--18.2)       15       1.4±0.6 (0.8--2.3)    6
  Albumin (g l^−1^)                                               31--43        35±40 (16--174)         14        30±2.2 (26--32)      6
  Bile acids (g l^−1^)                                             \<30       4.6±5.7 (0.0--20.4)       15       3.1±1.4 (1.2--4.6)    6
  PGFM[\*](#nt102){ref-type="table-fn"} (nmol l^−1^)                         3695±3674 (464--13000)     15       477±117 (360--640)    6
  SAA[\#](#nt103){ref-type="table-fn"} (µg ml^−1^)                            61.3±31 (\<5--\>80)       15             All\<5          6
  CRP[\*](#nt102){ref-type="table-fn"} (µg ml^−1^)                           38.5±17.5 (0.7--58.2)      15       1.3±1.2 (0.0--2.9)    6

WBC = total white blood cell count; BN = Band neutrophilic granulocytes; SN = segmented neutrophilic granulocytes; BaN = basophilic granulocytes; EoN = eosiniphilic granulocytes; ALAT = alanine aminotransferase; AP = alkaline phosphatase; PGFM = Prostaglandin F~2α~ metabolite, SAA = Serum amyloid A, CRP = C-reactive protein.

Statistically significant difference between the pyometra group and control group (Student\'s t-test),

difference not tested.

Histopathological Examinations {#s2d}
------------------------------

Pyometra diagnosis was performed by gross and histopathological examinations of haematoxylin-eosin-stained sections of uteri and ovaries. Diagnostic criteria for pyometra with or without concomitant presence of macro- and/or microscopically visible cystic dilatation and epithelial hyperplasia of endometrial glands were uterine distension of a varying degree with macroscopically visible presence of opaque, yellowish to brownish exudates in the uterine lumen and microscopically visible purulent inflammatory changes in the endometrium and cystic glands.

Microarray Expression Analysis and Data Analysis {#s2e}
------------------------------------------------

Total RNA was prepared from cross-sections of frozen uterine tissue samples, using Nucleospin RNA II (Macherey-Nagel, Düren, Germany). Affymetrix gene chip microarray analysis was performed using the Canine Genome 2.0 Array, as described [@pone.0008039-Wensman1]. The raw data were normalized using the robust multi-array average (RMA) [@pone.0008039-Irizarry1] background-adjusted, normalized and log-transformed summarized values. An empirical Bayes moderated *t-*test was applied to search for differentially expressed genes [@pone.0008039-Smyth1]. The *p*-values were adjusted to avoid the problem with multiple testing [@pone.0008039-Hochberg1]. The Genesis software, version 1.7.1 (<http://genome.tugraz.at/>), was used to perform hierarchical clustering and to visualize differentially expressed genes [@pone.0008039-Sturn1]. All data is MIAME compliant and that the raw data has been deposited in a MIAME compliant database (the data is accessible via GEO using the accession no: GSE17878).

Real-Time PCR {#s2f}
-------------

RNA was prepared using NucleoSpin® (Macherey-Nagel, Germany). First-Strand cDNA was synthesized with SuperScript™ II Reverse Transcriptase (Invitrogen, Inchinnan, UK) according to the manufacturers\' instructions with 5 µl RNA and a final concentration of 7.5 ng/µl random hexamers (Invitrogen) in a total volume of 20 µl. The cDNA concentration was determined, and the cDNA was diluted to 800 ng/µl. Real-time PCR (qPCR) was performed on a ABI PRISM 7900 HT using iQ™ SYBR Green Supermix (BioRad, CA, USA) in a total volume of 10 µl, containing 80 ng cDNA and a final primer concentration of 100--300 nM. PCR cycling conditions included a 95°C heating step of 10 min at the beginning of every run. The samples were then cycled 40 times at 95°C for 30 s (denaturation), 58°C for 20 s (annealing) and 72°C for 20 s (extension). A melting curve from 60°C to 90°C was generated at the end of every run. Prior to experiments, the primer efficiency for each primer pair was determined with three different dilutions of the cDNA. The C~T~-values were plotted against Log concentrations of the dilutions and primer efficiency was calculated according to following formula: efficiency = 10^(−1/slope)^-1. The results were calculated by the comparative C~T~ method (User Bulletin \#2: ABI PRISM 770 Sequence Detection System (P7N 4303859)), using Hypoxanthine guanine phosphoribosyl transferase (Hprt) as housekeeping gene. For primers used and primer efficiency, see [Table S1](#pone.0008039.s001){ref-type="supplementary-material"}.

Results {#s3}
=======

Clinical Data {#s3a}
-------------

Data from analyses of haematological, biochemical, acute phase protein and inflammatory parameters are displayed in [Table 1](#pone-0008039-t001){ref-type="table"}. As shown in [Fig. S1](#pone.0008039.s005){ref-type="supplementary-material"}, bacterial infection of the uterus was associated with a profound inflammatory reaction, primarily involving infiltration of mononuclear cells, and there was a particular abundance of plasma cells. Neutrophils and eosinophils were rarely present. In contrast, tissue from healthy individuals lacked signs of inflammation or tissue remodeling. Clinical data for the 4 dogs selected for Affymetrix gene chip analysis (see below) are illustrated in [Table 2](#pone-0008039-t002){ref-type="table"}. *Escherichia coli* were isolated from all 4 uteri selected for micro-array analysis, whereof 3 strains were haemolytic. By using clinical criteria for assessment of sepsis/systemic inflammatory response syndrome (SIRS) in dogs with the highest sensitivity (97%) and specificity (64%), three of the four selected dogs were determined SIRS-positive [@pone.0008039-Hauptman1]. In one of the dogs (case 3), peritonitis with pus in the abdomen was apparent during surgery.

10.1371/journal.pone.0008039.t002

###### Illustration of data from physical examinations, uterine bacterial cultures and postoperative hospitalisation in the 4 female dogs with bacterial uterine infection (pyometra) selected for micro array analysis.
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  Pyometra case         Uterine diameter (cm)    General condition       Temp(°C)     HR(/min)   RR(/min)   WBC(10^9^ l^−1^)   PBN(%)   SIRS   Animal hospital stay (days)
  -------------------- ----------------------- ---------------------- -------------- ---------- ---------- ------------------ -------- ------ -----------------------------
  *Reference values*            *\<1*                 *Normal*         *38.0--39.0*   *\<120*    *20--40*      5.2--14.1        *−*     *−*                *2*
  11                             3.5              Mildly depressed         39.5         120         46            10.6           12      \+                 4
  12                             4.0            Moderately depressed       39.3         100         20            32.7           42      \+                 2
  13                             5.0              Mildly depressed         39.6         140         20            26.8           35      \+                 4
  16                             2.0              Mildly depressed         38.3         100         20            29.3          0.1      −                  2

Temp = Core temperature, HR = heart rate, RR = respiratory rate, WBC = total white blood cell count, PBN = percentage band neutrophils, SIRS = systemic inflammatory response syndrome.

Affymetrix Gene Chip Analysis {#s3b}
-----------------------------

In order to investigate the molecular events associated with the infection, total RNA extracted from uterine tissue of 4 diseased and 4 healthy control animals (blood parameters specified in [Table S2](#pone.0008039.s002){ref-type="supplementary-material"}) were subjected to Affymetrix gene chip microarray analysis. A hierarchic clustering of the samples revealed that the control and pyometra groups, respectively, clustered well together ([Fig. S2](#pone.0008039.s006){ref-type="supplementary-material"}). Using moderated t-statistics we analyzed for differentially expressed genes, using a 2-fold change and adj p\<0.05 as thresholds for significance. This analysis revealed that almost 800 genes were significantly upregulated more than 2-fold. In [Table 3](#pone-0008039-t003){ref-type="table"}, the 50 genes showing the largest extent of upregulation are listed and [Table S3](#pone.0008039.s003){ref-type="supplementary-material"} displays the complete list of significantly upregulated genes. We also found that almost 700 genes were significantly (adj p\<0.05) downregulated more than 2-fold. The 50 genes showing the largest extent of downregulation are depicted in [Table 4](#pone-0008039-t004){ref-type="table"}, and [Table S4](#pone.0008039.s004){ref-type="supplementary-material"} displays the complete list of downregulated genes. An examination of the significantly up- and downregulated genes revealed distinct gene families that were highly represented, and these were selected for further analysis and visualization.

10.1371/journal.pone.0008039.t003

###### 50 genes showing the highest extent of significant (adj p\<0.05) upregulation, in comparison with healthy controls, in uterus from animals diagnosed with uterine bacterial infection.
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  Gene Title                                                       Gene symbol              ID              Fold change   adj. *p*. val
  --------------------------------------------------------------- ------------- -------------------------- ------------- ---------------
  secretory leukocyte peptidase inhibitor                             SLPI       CfaAffx.15167.1.S1_s\_at      344,8         0,0006
  interleukin 8                                                        IL8           Cfa.3510.1.S2_at          242,9         0,0003
  sphingomyelin phosphodiesterase, acid-like 3A                      SMPDL3A     CfaAffx.2399.1.S1_s\_at       194,4         0,0002
  S100 calcium binding protein A9                                    S100A9       CfaAffx.26854.1.S1_at        160,7         0,0002
  interferon induced transmembrane protein 2                         IFITM2      CfaAffx.10684.1.S1_s\_at      137,3         0,0002
  similar to Ig lambda chain V region 4A precursor                  LOC612066     CfaAffx.345.1.S1_s\_at       129,5         0,0018
  similar to Ig kappa chain C region, B allele                      LOC475754     Cfa.12195.14.S1_s\_at        124,8         0,0053
  insulin-like growth factor binding protein 1                       IGFBP1      CfaAffx.19068.1.S1_s\_at      104,4         0,0004
  similar to Ig heavy chain V-III region VH26 precursor             LOC490894      Cfa.4556.3.A1_a\_at         94,5          0,0010
  prostaglandin-endoperoxide synthase 2                               PTGS2        Cfa.3449.1.S1_s\_at         88,7          0,0017
  serum amyloid A protein /// serum amyloid A1                        SAA1        CfaAffx.14443.1.S1_at        65,9          0,0031
  S100 calcium binding protein A8                                    S100A8       CfaAffx.26852.1.S1_at        56,6          0,0007
  haptoglobin-related protein                                          HPR         Cfa.12245.2.A1_a\_at        56,1          0,0025
  similar to Immunoglobulin lambda-like polypeptide 1 precursor     LOC607558        Cfa.4465.2.S1_at          53,3          0,0010
  serglycin                                                           SRGN         Cfa.20785.1.S1_s\_at        53,2          0,0002
  similar to immunoglobulin iota chain preproprotein                LOC486411      Cfa.4465.2.S1_s\_at         50,7          0,0010
  similar to Ig lambda chain V-I region BL2 precursor               LOC607020     CfaAffx.265.1.S1_s\_at       49,8          0,0162
  complement component 6                                               C6        CfaAffx.28425.1.S1_s\_at      48,5          0,0014
  tissue factor pathway inhibitor 2                                   TFPI2        CfaAffx.3983.1.S1_at        48,1          0,0016
  chemokine (C-X-C motif) ligand 14                                  CXCL14      CfaAffx.2498.1.S1_s\_at       47,0          0,0010
  chemokine (C-C motif) ligand 2                                      CCL2         Cfa.3851.1.S1_s\_at         44,8          0,0008
  matrix metallopeptidase 1 (interstitial collagenase)                MMP1       CfaAffx.23166.1.S1_s\_at      44,7          0,0139
  complement component 5a receptor 1                                  C5AR1          Cfa.3834.1.S1_at          43,4          0,0002
  CD5 molecule-like                                                   CD5L           Cfa.5955.1.S1_at          42,6          0,0068
  Fc fragment of IgG, high affinity Ia, receptor (CD64)              FCGR1A         Cfa.173.1.A1_s\_at         42,5          0,0004
  macrophage receptor with collagenous structure                      MARCO        Cfa.15713.1.A1_s\_at        40,7          0,0002
  similar to Small inducible cytokine A23 precursor (CCL23)         LOC480602       Cfa.12237.1.A1_at          40,7          0,0007
  neutrophil cytosolic factor 2                                       NCF2           Cfa.2804.1.S1_at          39,7          0,0001
  CD48 molecule                                                       CD48          Cfa.14560.1.S1_at          38,9          0,0001
  acyloxyacyl hydrolase (neutrophil)                                  AOAH         CfaAffx.5812.1.S1_at        37,0          0,0001
  thrombospondin 4                                                    THBS4      CfaAffx.14209.1.S1_s\_at      31,2          0,0033
  chemokine (C-X-C motif) ligand 10                                  CXCL10         Cfa.16590.1.S2_at          31,1          0,0264
  similar to Small inducible cytokine A4 precursor (CCL4)           LOC480601      Cfa.5334.1.A1_s\_at         30,8          0,0020
  similar to Ig kappa chain V-II region RPMI 6410 precursor         LOC491492    CfaAffx.23613.1.S1_x\_at      30,0          0,0114
  matrix metallopeptidase 9 (gelatinase B)                            MMP9         Cfa.3470.1.S1_s\_at         29,4          0,0001
  selectin L                                                          SELL       CfaAffx.23335.1.S1_s\_at      28,3          0,0004
  similar to normal mucosa of esophagus specific 1                  LOC478287    CfaAffx.25306.1.S1_x\_at      28,2          0,0036
  caspase 4, apoptosis-related cysteine peptidase                     CASP4        Cfa.3589.1.S1_s\_at         28,1          0,0002
  similar to immunoglobulin J chain                                 LOC475166    CfaAffx.5291.1.S1_s\_at       27,7          0,0022
  secreted phosphoprotein 1                                           SPP1           Cfa.9240.1.S1_at          27,7          0,0038
  CD163 molecule                                                      CD163          Cfa.9647.1.A1_at          27,5          0,0010
  chemokine (C-X-C motif) ligand 14                                  CXCL14         Cfa.21149.1.S1_at          27,5          0,0005
  plasminogen activator inhibitor type 1                            SERPINE2      CfaAffx.24902.1.S1_at        25,6          0,0004
  peptidase inhibitor 3, skin-derived (SKALP)                          PI3       CfaAffx.15155.1.S1_s\_at      24,1          0,0044
  similar to normal mucosa of esophagus specific 1                  LOC478287       Cfa.11815.1.A1_at          23,8          0,0067
  lymphocyte cytosolic protein 2                                      LCP2          Cfa.18362.1.S1_at          23,4          0,0002
  regenerating islet-derived 3 gamma                                  REG3G        Cfa.16734.1.S1_s\_at        23,2          0,0474
  Fc fragment of IgG, low affinity IIIa, receptor (CD16a)            FCGR3A         Cfa.21258.1.S1_at          23,2          0,0010
  membrane-spanning 4-domains, subfamily A, member 7                  MS4A7       CfaAffx.16226.1.S1_at        22,7          0,0015

10.1371/journal.pone.0008039.t004

###### 50 genes showing the highest extent of significant (adj p\<0.05) downregulation, in comparison with healthy controls, in uterus from animals diagnosed with uterine bacterial infection.
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  Gene title                                                          Gene symbol              ID              Fold change   adj. *p*. val
  ------------------------------------------------------------------ ------------- -------------------------- ------------- ---------------
  sulfotransferase                                                      SULT1D1         Cfa.3502.1.S1_at          −30,6          0,018
  EPH receptor A7                                                        EPHA7      CfaAffx.6057.1.S1_s\_at       −26,0          0,003
  transcription factor CP2-like 1                                       TFCP2L1        Cfa.15666.1.A1_at          −15,2          0,002
  synuclein, alpha interacting protein                                  SNCAIP        Cfa.13718.1.S1_s\_at        −10,9          0,001
  fasciculation and elongation protein zeta 1 (zygin I)                  FEZ1         Cfa.18202.2.S1_a\_at        −10,7          0,042
  similar to phosphatidylethanolamine-binding protein 4                LOC608950       Cfa.17117.1.S1_at          −10,6          0,004
  similar to esophageal cancer related gene 4 protein                  LOC611190      CfaAffx.4062.1.S1_at        −10,5          0,001
  trefoil factor 2                                                       TFF2           Cfa.201.1.S1_at           −9,2           0,048
  regulator of G-protein signaling 22                                    RGS22        CfaAffx.1736.1.S1_at        −8,9           0,002
  epoxide hydrolase 2, cytoplasmic                                       EPHX2          Cfa.574.1.A1_at           −8,3           0,001
  Norrie disease (pseudoglioma)                                           NDP           Cfa.4725.1.S1_at          −8,3           0,007
  ankyrin 3, node of Ranvier (ankyrin G)                                 ANK3       CfaAffx.19834.1.S1_s\_at      −8,1           0,003
  rhophilin, Rho GTPase binding protein 2                                RHPN2           Cfa.15.1.S1_at           −8,0           0,006
  hydroxypyruvate isomerase homolog (E. coli)                             HYI       CfaAffx.8731.1.S1_s\_at       −7,9           0,004
  ectonucleotide pyrophosphatase/phosphodiesterase 6                     ENPP6       CfaAffx.12520.1.S1_at        −7,9           0,012
  msh homeobox 2                                                         MSX2           Cfa.3529.1.S1_at          −7,9           0,014
  forkhead box A2                                                        FOXA2         Cfa.13382.1.A1_at          −7,8           0,007
  similar to Homeobox protein DLX-6                                    LOC482312      CfaAffx.4169.1.S1_at        −7,5           0,001
  distal-less homeobox 5                                                 DLX5         CfaAffx.4173.1.S1_at        −7,4           0,006
  solute carrier family 30 (zinc transporter), member 2                 SLC30A2         Cfa.5561.1.A1_at          −7,4           0,014
  lymphoid enhancer-binding factor 1                                     LEF1       CfaAffx.17535.1.S1_s\_at      −7,4           0,019
  F-box and WD repeat domain containing 10                              FBXW10         Cfa.11549.1.A1_at          −7,3           0,026
  cholecystokinin                                                         CCK       CfaAffx.8825.1.S1_s\_at       −7,1           0,027
  aldehyde dehydrogenase 1 family, member A1                            ALDH1A1         Cfa.1715.1.S1_at          −7,1           0,018
  epoxide hydrolase 2, cytoplasmic                                       EPHX2      CfaAffx.13394.1.S1_s\_at      −7,0           0,001
  glutamate-cysteine ligase, catalytic subunit                           GCLC       CfaAffx.4309.1.S1_s\_at       −7,0           0,014
  phosphatidic acid phosphatase type 2 domain containing 1A            PPAPDC1A         Cfa.5652.1.A1_at          −6,9           0,023
  similar to RIKEN cDNA 5133401N09                                     LOC484150      CfaAffx.3054.1.S1_at        −6,6           0,042
  protein phosphatase 1, regulatory (inhibitor) subunit 1B              PPP1R1B        Cfa.20636.1.S1_at          −6,6           0,027
  similar to Epithelial-cadherin precursor (E-cadherin)                LOC489647     CfaAffx.30291.1.S1_at        −6,6           0,009
  DEP domain containing 7                                               DEPDC7       CfaAffx.11821.1.S1_at        −6,6           0,044
  similar to EGFR-coamplified and overexpressed protein                LOC608562       Cfa.20305.1.S1_at          −6,6           0,009
  betaine-homocysteine methyltransferase                                 BHMT          Cfa.11111.1.A1_at          −6,5           0,002
  N-acetylated alpha-linked acidic dipeptidase 2                        NAALAD2     CfaAffx.7397.1.S1_s\_at       −6,4           0,038
  similar to dachshund homolog 1 isoform a                             LOC485489      CfaAffx.8384.1.S1_at        −6,4           0,016
  carboxylesterase 2 (intestine, liver)                                  CES2          Cfa.19114.1.S1_at          −6,3           0,005
  msh homeobox 1                                                         MSX1        CfaAffx.24056.1.S1_at        −6,3           0,010
  spermatid perinuclear RNA binding protein                              STRBP         Cfa.19369.1.S1_at          −6,2           0,002
  EF-hand domain (C-terminal) containing 2                               EFHC2        Cfa.9584.1.A1_s\_at         −6,1           0,001
  cystathionase (cystathionine gamma-lyase)                               CTH           Cfa.359.1.S1_at           −6,1           0,005
  SH3 domain binding glutamic acid-rich protein like 2                 SH3BGRL2     CfaAffx.5151.1.S1_s\_at       −6,0           0,033
  glutamate receptor interacting protein 1                               GRIP1        Cfa.8622.1.A1_s\_at         −5,9           0,006
  CKLF-like MARVEL transmembrane domain containing 8                     CMTM8        Cfa.8530.1.A1_s\_at         −5,7           0,017
  tumor-associated calcium signal transducer 1                          TACSTD1       CfaAffx.4844.1.S1_at        −5,7           0,004
  similar to myosin 18A isoform b                                      LOC475308      Cfa.1186.1.A1_s\_at         −5,6           0,003
  similar to ankyrin repeat domain 26                                  LOC610965     CfaAffx.12169.1.S1_at        −5,6           0,009
  WNT inhibitory factor 1                                                WIF1           Cfa.4881.1.A1_at          −5,5           0,018
  similar to Arg/Abl-interacting protein 2 isoform 1                   LOC482906    CfaAffx.12091.1.S1_s\_at      −5,4           0,012
  RAS guanyl releasing protein 1 (calcium and DAG-regulated)            RASGRP1         Cfa.7809.1.A1_at          −5,4           0,040
  similar to membrane-associated guanylate kinase-related (MAGI-3)     LOC479761     CfaAffx.24689.1.S1_at        −5,4           0,008

Chemokines and Chemokine Receptors {#s3c}
----------------------------------

A large number of chemokine genes were found among the most upregulated genes ([Fig. 1](#pone-0008039-g001){ref-type="fig"}; [Tables 3](#pone-0008039-t003){ref-type="table"} and [S3](#pone.0008039.s003){ref-type="supplementary-material"}). Not only did we find a number of CCL and CXCL chemokines, we also found a number of chemotactic proteins of the S100 family among the highly upregulated genes. In fact, S100A9 and S100A8 were among the genes showing the highest degree of upregulation of all genes. Out of the CCL and CXCL chemokines, CXCL14/BRAK and CCL2/MCP-1 showed the highest extent of upregulation. Among the chemokine receptors, CCR5 was upregulated to the largest extent.

![Heat map of differentially expressed chemokine, S100 protein and chemokine receptor genes in uteri from control animals and animals with pyometra (n = 4).\
The normalized 2 log intensity values were centered to the median value of each probe set and colored on a range of −3 to +3. Red denotes upregulated expression levels, and green denotes downregulated expression levels as compared with the median value.](pone.0008039.g001){#pone-0008039-g001}

Cytokines {#s3d}
---------

As displayed in [Fig. 2](#pone-0008039-g002){ref-type="fig"} and [Table 3](#pone-0008039-t003){ref-type="table"}/[S3](#pone.0008039.s003){ref-type="supplementary-material"}, a number of cytokines were upregulated in the uteri of diseased animals, with IL-8, IL-1 and IL-6 showing the highest extent of induction and there was also a high extent of IL-1 receptor upregulation. Also IL-33 and IL-18 were markedly upregulated. Somewhat unexpectedly, no significant upregulation of TNF or of any of the interferon family members was seen. In line with the upregulated cytokine expression, we noted a significant (3.3-fold) downregulation of suppressor of cytokine signaling 6 (SOCS6)([Table S4](#pone.0008039.s004){ref-type="supplementary-material"}).

![Heat map of differentially expressed cytokine receptor genes in uteri from control animals and animals with pyometra (n = 4).\
The normalized 2 log intensity values were centered to the median value of each probe set and colored on a range of −3 to +3. Red denotes upregulated expression levels, and green denotes downregulated expression levels as compared with the median value.](pone.0008039.g002){#pone-0008039-g002}

Complement System {#s3e}
-----------------

The uterine infection caused a marked upregulation of a number of genes related to the complement system ([Fig. 3](#pone-0008039-g003){ref-type="fig"}; [Tables 3](#pone-0008039-t003){ref-type="table"}/[S3](#pone.0008039.s003){ref-type="supplementary-material"}). Notably, both the classical and alternative pathways were represented, as shown by the upregulation of both C1 (classical pathway) as well as of Factors D, B and properdin (alternative pathway). Also C3 and C6, i.e. components that are shared by both pathways, were upregulated. Genes involved in the downregulation of the complement system were also upregulated, as shown by the strong upregulation of the C1 inhibitor: serpin peptidase inhibitor (clade G), member 1, and of Factor H. The C5a receptor was also dramatically upregulated.

![Heat map of differentially expressed complement-related genes in uteri from control animals and animals with pyometra (n = 4).\
The normalized 2 log intensity values were centered to the median value of each probe set and colored on a range of −3 to +3. Red denotes upregulated expression levels, and green denotes downregulated expression levels as compared with the median value.](pone.0008039.g003){#pone-0008039-g003}

Proteases/Protease Inhibitors {#s3f}
-----------------------------

An examination of the list of upregulated genes reveals a striking representation of genes related to proteolysis. Notably, the gene that showed the highest extent of upregulation among all genes was a protease inhibitor, secretory leukocyte peptidase inhibitor (SLPI; [Table 3](#pone-0008039-t003){ref-type="table"} and [Fig. 4](#pone-0008039-g004){ref-type="fig"}), and its profound upregulation in diseased animals was confirmed by qPCR analysis ([Fig. 5A](#pone-0008039-g005){ref-type="fig"}). SLPI is an inhibitor of neutrophil elastase and strong upregulation (∼24-fold) was also seen for an additional elastase inhibitor, SKALP/elafin ([Table 3](#pone-0008039-t003){ref-type="table"} and [Fig. 4](#pone-0008039-g004){ref-type="fig"}). Numerous matrix metalloprotease (MMP) members were upregulated, including the collagenases MMP-1 and MMP-13, as well as the gelatinase MMP-9 and MMP-7/matrilysin ([Fig. 4](#pone-0008039-g004){ref-type="fig"} and [Table 3](#pone-0008039-t003){ref-type="table"}/[S3](#pone.0008039.s003){ref-type="supplementary-material"}). The robust upregulation of MMP-1 and MMP-9 was confirmed by qPCR analysis ([Fig. 5B, C](#pone-0008039-g005){ref-type="fig"}). There was also a striking induction of TIMP-1, and -2, i.e. protease inhibitors with specificity for inhibiting proteases belonging to the MMP family ([Fig. 4](#pone-0008039-g004){ref-type="fig"}). Several proteases of the a disintegrin and metalloproteinase (ADAM) and ADAM with thrombospondin type 1-like motifs (ADAMTS) families were also markedly upregulated: ADAMTS2, ADAMTS5, ADAMDEC1 and ADAM28. Significant induction was also seen for various cysteine proteases, including caspase 4, -12 and -8, and several cysteine cathepsins, including cathepsin H, -S, -C and --B. Cathepsin D, an aspartic protease, was also significantly upregulated. Out of the large family of serine protease genes, the urokinase plasminogen activator gene showed the highest extent of upregulation and this was also reflected by a large extent of upregulation for the corresponding inhibitor, i.e. plasminogen activator inhibitor 1 (PAI-1). An upregulated expression of various mast cell proteases was also evident. In particular, a significant upregulation of mastin, a tetrameric, tryptase-like protease with gelatinase activity [@pone.0008039-Raymond1] was seen in diseased uteri.

![Heat map showing upregulated expression of protease and protease inhibitor genes in uteri from control animals and animals with pyometra (n = 4).\
The normalized 2 log intensity values for 50 genes (out of total 172 genes filtered as proteases/protease inhibitors) were centered to the median value of each probe set and colored on a range of -3 to +3. Red indicates upregulated expression, and green indicates downregulated expression as compared with the median value.](pone.0008039.g004){#pone-0008039-g004}

![qPCR analysis confirming the up- or downregulation of selected genes in uterine tissue from dogs with pyometra.\
(A) SLPI; (B) MMP1; (C) MMP9; (D) SRGN; (E) MSX2; (F) HOXA6. All values are relative to one of the control samples. n = 7 (control); n = 5 (pyometra). p\<0.05 \*; p\<0.01 \*\*; p\<0.001 \*\*\*; Student\'s t-test](pone.0008039.g005){#pone-0008039-g005}

Proteoglycans/Anticoagulant Pathways {#s3g}
------------------------------------

One of the genes that showed the highest extent of upregulation was the gene coding for the core protein of serglycin proteoglycan (SRGN), as shown both by Affymetrix gene chip analysis ([Fig. 6](#pone-0008039-g006){ref-type="fig"}) and by qPCR ([Fig. 5D](#pone-0008039-g005){ref-type="fig"}). Significant upregulation was also seen for versican, lumican, syndecan-2, biglycan and syndecan-4 ([Fig. 6](#pone-0008039-g006){ref-type="fig"} and [Tables 3](#pone-0008039-t003){ref-type="table"}/[S3](#pone.0008039.s003){ref-type="supplementary-material"}). The biological properties of proteoglycans are critically dependent on the nature of the glycosaminoglycan chains (heparan/chondroitin/dermatan/keratan sulfate or heparin) attached to the respective protein cores. Glycosaminoglycan chain synthesis is accomplished through the concerted action of a number of biosynthetic enzymes and we therefore analyzed the expression of the corresponding genes. As shown in [Fig. 6](#pone-0008039-g006){ref-type="fig"}, a strong induction of two heparan sulfate 3-O-sulfotransferase isoforms (HS3ST3A1 and HS3ST3B1) was evident in uterus from infected individuals and upregulation of the genes coding for dermatan sulfate epimerase, carbohydrate (chondroitin 4) sulfotransferase 11 and chondroitin sulfate N-acetylgalactosaminyltransferase 2 was also apparent ([Fig. 6](#pone-0008039-g006){ref-type="fig"}). Heparan sulfate 3-O-sulfotransferase catalyzes the incorporation of GlcNAc-3-O-sulfate into heparan sulfate and mast cell heparin, thereby conferring the respective glycosaminoglycan with potent anticoagulant activity [@pone.0008039-Lindahl1]. Hence, the upregulated expression of the corresponding genes suggests that activation of anticoagulant mechanisms is a feature of bacterial infection of the uterus. In agreement with this notion, strong upregulation (48-fold) of another anticoagulant component, tissue factor pathway inhibitor 2, was also evident ([Table 3](#pone-0008039-t003){ref-type="table"}). The role of anticoagulant pathways in the regulation of bacterial disease is also underscored by the established use of activated protein C, an anticoagulant protein, in treatment of sepsis [@pone.0008039-Houston1].

![Heat map of differentially expressed proteoglycan genes and genes related to biosynthesis of the glycosaminoglycan component of proteoglycans (n = 4).\
The normalized 2 log intensity values for 30 genes (out of total 72 filtered genes) were centered to the median value of each probe set and colored on a range of -3 to +3. Red denotes upregulated expression levels, and green denotes downregulated expression levels as compared with the median value.](pone.0008039.g006){#pone-0008039-g006}

Prostaglandins {#s3h}
--------------

The uterine infection caused a massive (∼90-fold) upregulation of the prostaglandin-endoperoxide synthase 2/cyclooxygenase-2 gene (PTGS2)([Table 3](#pone-0008039-t003){ref-type="table"}). Further, strong upregulation of the prostaglandin D2 receptor (PTGDR) and prostaglandin E synthase (PTGES) genes was evident ([Table 3](#pone-0008039-t003){ref-type="table"}/[S3](#pone.0008039.s003){ref-type="supplementary-material"}). The upregulation of prostaglandin-related genes is thus in accordance with the increased levels of prostaglandin F~2α~ metabolite in plasma from diseased dogs ([Table 1](#pone-0008039-t001){ref-type="table"}). In contrast, genes related to leukotriene metabolism were not affected to any major extent.

Immunoglobulins, Antigen Presentation {#s3i}
-------------------------------------

Various immunoglobulin (Ig)-related genes were highly represented ([Table 3](#pone-0008039-t003){ref-type="table"}/[S3](#pone.0008039.s003){ref-type="supplementary-material"}), for example, Ig lambda chain V region 4A precursor, Ig kappa chain C region and Ig heavy chain V-III region VH26 precursor. In agreement with a strong upregulation of Ig genes, plasma cells were abundant in afflicted tissue ([Fig. S1](#pone.0008039.s005){ref-type="supplementary-material"}). Several genes associated with antigen presentation were also upregulated, including MHC class II DR alpha chain and MHC class II DLA DRB1 beta chain, CD48 (adhesion molecule involved in the immunological synapse) as well as cathepsin S, the latter being a cysteine protease implicated in antigen processing [@pone.0008039-Gupta1].

Anti-Bacterial Genes {#s3j}
--------------------

A natural consequence of the uterine infection would be an upregulated expression of various anti-bacterial proteins. Indeed, strong upregulated expression of lysozyme was apparent and there was also a marked upregulation of acyloxyacyl hydrolase, a lipase that partially deacylates bacterial lipopolysaccharide (LPS)([Table 3](#pone-0008039-t003){ref-type="table"}/[S3](#pone.0008039.s003){ref-type="supplementary-material"}). Strong induction was also seen for regenerating islet-derived 3 gamma (REG3G), an anti-bacterial compound that is expressed in an IL-22 and IL-23p19-dependent fashion [@pone.0008039-Godinez1], [@pone.0008039-Zheng1], and of bactericidal/permeability-increasing protein (BPI), the latter being an antimicrobial protein with LPS-neutralizing activity [@pone.0008039-Canny1]. Moreover, clear upregulation of the anti-bacterial chemokines [@pone.0008039-Cole1], CXCL14 [@pone.0008039-Maerki1] and CCL20 was evident. Somewhat unexpectedly, we did not see a significantly upregulated expression of any of the defensin family members.

Acute-Phase Reactants {#s3k}
---------------------

Pyometra and other bacterial infections are associated with elevated plasma levels of various acute phase reactants [@pone.0008039-Ceron1], [@pone.0008039-Fransson1]. Although the liver is considered to be the primary source for this group of proteins, it is apparent that several acute-phase reactants are also produced within the uterus, as shown by the dramatic (∼160-fold) upregulation of serum amyloid A (SAA)([Table 3](#pone-0008039-t003){ref-type="table"}). Notably, the strong upregulation of the SAA gene is consistent with the high levels of SAA found in serum from diseased animals ([Table 1](#pone-0008039-t001){ref-type="table"}).

Pattern Recognition Receptors {#s3l}
-----------------------------

The onset of innate immunity reactions is typically triggered through the various pattern recognition receptors, including the toll-like receptors (TLRs). Out of these, we detected significant upregulation of, in particular, TLR2 (∼9-fold), but also TLR1 (∼5-fold) and, to a somewhat lesser extent, TLR4 (∼2.4-fold)([Table S3](#pone.0008039.s003){ref-type="supplementary-material"}). There was also a profound upregulation of the mannose receptor (∼17-fold) and of several C type lectins: CLEC5A (∼14-fold), CLEC2D (13-fold), CLEC12A (7-fold), CLEC4D (4.5-fold) and CLEC4E (3.4-fold)([Table S3](#pone.0008039.s003){ref-type="supplementary-material"}), but no significant upregulation of nucleotide-binding and oligomerization (NOD) 1 or NOD2.

Cell Adhesion/Extravasation {#s3m}
---------------------------

Cell adhesion to the endothelium is a crucial step in the inflammatory process. Accordingly, several endothelial adhesion molecules were significantly upregulated in infected animals, in particular selectin L (28-fold), VCAM-1 (18-fold), selectin P (8.5-fold), ICAM-1 (7.6-fold) and selectin E (4-fold)([Table 3](#pone-0008039-t003){ref-type="table"}/[S3](#pone.0008039.s003){ref-type="supplementary-material"}). We also detected significantly downregulated expression of several genes involved in endothelial cell-cell contact formation, including genes coding for E-cadherin (6.6-fold), catenin (cadherin-associated protein), delta 2 (5.1-fold), cadherin 18, type 2 (4.7-fold), protocadherin 11 (3.7-fold) and occludin (3.3-dold). Clearly, the downregulated expression of the latter compounds is likely to enhance endothelial permeability and, hence, promote inflammatory cell infiltration into the uterus.

Other Upregulated Genes {#s3n}
-----------------------

Among the remaining, upregulated genes, the gene coding for Sphingomyelin phosphodiesterase, acid-like 3A (SMPDL3A) showed the most dramatic extent of induction, being increased almost 200-fold in uteri from diseased animals ([Table 3](#pone-0008039-t003){ref-type="table"}). Sphingomyelin phosphodiesterase is an enzyme that hydrolyzes sphingomyelin to ceramide and phosphorylcholine and, noteworthy, ceramide has been implicated in various pathophysiologial settings including apoptosis and infectious disease [@pone.0008039-Schenck1]. Other examples of profoundly (over 20-fold) upregulated genes included interferon induced transmembrane protein 2 (IFITM2), insulin-like growth factor binding protein 1 (IGFBP1), CD5 molecule-like (CD5L), lymphocyte cytosolic protein 2, CD48, thrombospondin 4, secreted phosphoprotein 1 (osteopontin), CD163, membrane-spanning 4-domains, subfamily A, member 7 (MS4A7) and Growth-associated protein-43 (GAP-43) ([Tables 3](#pone-0008039-t003){ref-type="table"}/[S3](#pone.0008039.s003){ref-type="supplementary-material"}).

Downregulated Genes/Homeobox and Zinc Finger Transcription Factors {#s3o}
------------------------------------------------------------------

The genes that were significantly downregulated in diseased animals included a number of genes with functions associated with signaling pathways ([Table 4](#pone-0008039-t004){ref-type="table"}/[S4](#pone.0008039.s004){ref-type="supplementary-material"}). In particular, we note a striking presence of numerous members of the homeobox ([Fig. 7](#pone-0008039-g007){ref-type="fig"}) and zinc finger ([Fig. 8](#pone-0008039-g008){ref-type="fig"}) transcription factor families. The strong downregulation of homeobox genes in dogs afflicted with pyometra was also verified by qPCR analysis, as shown for MSX2 and HOXA6 ([Fig. 5E, F](#pone-0008039-g005){ref-type="fig"}). Notably, of all significantly downregulated (more than 2-fold) genes, 16 homeobox genes and 54 zinc finger genes were found. In contrast, homeobox and zinc finger proteins were only minimally represented (altogether 3 genes) among the significantly upregulated genes, being absent from the 100 most upregulated genes.

![Heat map showing downregulated expression of homeobox genes in uteri from control animals and animals with pyometra (n = 4).\
The normalized 2 log intensity values for 50 homeobox genes (out of 176) were centered to the median value of each probe set and colored on a range of −3 to +3. Red denotes upregulated expression levels, and green denotes downregulated expression levels as compared with the median value.](pone.0008039.g007){#pone-0008039-g007}

![Heat map showing downregulated expression of zinc finger protein genes in uteri from control animals and animals with pyometra (n = 4).\
The normalized 2 log intensity values for 50 zinc finger genes (out of 489) were centered to the median value of each probe set and colored on a range of −3 to +3. Red denotes upregulated expression levels, and green denotes downregulated expression levels as compared with the median value.](pone.0008039.g008){#pone-0008039-g008}

Other examples of markedly downregulated genes included SULT1D1 (∼30-fold; coding for sulfotransferase), EPHA7 (∼26-fold; coding for EPH receptor A7), TFCP2L1 (∼15-fold; coding for transcription factor CP2-like 1) and SNCAIP (∼11-fold; coding for synuclein, alpha interacting protein)([Table 4](#pone-0008039-t004){ref-type="table"}).

Discussion {#s4}
==========

To the best of our knowledge, this is the first study in which the global gene expression pattern in the uterus is studied following a naturally occurring bacterial infection. Importantly, since a spontaneous disease rather than experimentally induced infection was used, the findings reflect a clinically relevant situation. Notably, previous attempts to extrapolate findings derived from experimental models of sepsis into a clinical setting have often encountered serious problems [@pone.0008039-Dyson1]. Another advantage of using the canine uterine disease as a model for sepsis is that the surgical treatment of the disease produces tissue samples readily available for studies of the local inflammatory response to bacterial infection. This is in contrast to corresponding human diseases, in which investigations are often limited to the use of blood sampling [@pone.0008039-Johnson1], [@pone.0008039-Tang2], [@pone.0008039-Wong1].

The pattern of upregulated genes clearly reflects an ongoing inflammatory response, as shown by the upregulated expression of several endothelial adhesion molecules, chemotactic proteins and cytokines. Among the cytokines, IL-6 and IL-1 were upregulated to the largest extent, and this was also reflected by a strong induction of the IL-1 receptor. Marked upregulation of IL-18 and IL-33 was also evident. Notably, IL-1, IL-18 and IL-33 are closely related cytokines, sharing structural and functional properties and, in addition, they are all activated by a caspase-1/inflammasome-dependent pathway [@pone.0008039-Arend1]. We may thus suggest that activation of the inflammasome constitutes a major pathway for driving the inflammation seen in diseased animals. Given the wide implication of TNF during the host response to a plethora of pathogens, it was expected that pyometra would be associated with robust upregulation of TNF. However, the TNF gene was only marginally (∼1.5-fold) upregulated, not even reaching statistical significance. Most likely, this apparent paradox may reflect that the samples were taken from animals that had reached a late stage of disease, a stage where the initial rise in TNF levels during the early phase of infection may have declined. Following this, targeting of TNF may not constitute the most optimal regimen for therapy and, indeed, clinical trials for sepsis in which TNF was targeted have shown limited success (discussed in [@pone.0008039-Dyson1]).

As judged from the present study, a major feature of uterine infection is the upregulated expression of a large panel of proteases. In particular, there was a profound upregulation of various MMP members implicated in extracellular matrix (ECM) and chemokine [@pone.0008039-Overall1] turnover, including collagenases (MMP-1, MMP-13), MMP-9 and MMP-7. We also note a robust upregulation of several caspases, a family of cysteine proteases strongly implicated in apoptotic processes, but also in a variety of other settings such as cancer and inflammation [@pone.0008039-Li1]. Out of the caspases, the most dramatic upregulation was seen for caspase-4, an "inflammatory" caspase that has been shown to promote nuclear factor kappa B (NF-κB) signaling and production of pro-inflammatory chemokines [@pone.0008039-Lakshmanan1]. Also caspase-8 was upregulated. Caspase-8 is widely implicated in apoptosis but may also contribute to NF-κB activation through TLR4 [@pone.0008039-Maelfait1]. Hence, its robust upregulation during uterine infection is in clear agreement with activation of the NF-κB pathway. Interestingly, strong upregulation was also seen for caspase-12, a protease that was recently shown to downregulate NF-κB signaling, thereby dampening the production of antibacterial peptides [@pone.0008039-LeBlanc1]. Hence, the uterine infection is associated with caspases capable of both promoting and dampening NF-κB-mediated effects on the immune system.

Uterine infection also caused a strong induction of several cysteine cathepsins. Traditionally, cystein cathepsins are mostly known as lysosomal enzymes involved in intracellular degradation processes. However, more recent data have revealed a much wider repertoire of functions, extending from roles in apoptosis to roles in cancer progression, wound healing and also in inflammatory disorders [@pone.0008039-Vasiljeva1]. The present report thus indicates that cysteine cathepsin induction is a prominent feature of bacterial uterine infection. The uterine infection was also associated with a marked upregulation of several ADAM and ADAMTS metalloproteases, primarily ADAMTS2, ADAMTS5, ADAMDEC1 and ADAM28. Previous studies have implicated ADAMTS proteases mainly in ECM turnover and in regulation of angiogenesis [@pone.0008039-Porter1] and the present report thus introduces the possibility that certain members of this protease family participate in bacterial disease. Members of the ADAM family have previously been implicated in a variety of disorders, such as asthma, cancer and autoimmune disease [@pone.0008039-Edwards1], but we are not aware of any previous in vivo evidence suggesting an involvement of any of the ADAM proteases in bacterial disease.

Since uncontrolled activation of proteolytic pathways may be harmful, it is critical that proteolytic activities are in balance with corresponding inhibitors. Indeed, a major finding in this study was the strong upregulation of various protease inhibitors. Strikingly, out of all upregulated genes, the gene coding for SLPI showed the highest extent of upregulation (∼340-fold). SLPI is an inhibitor of neutrophil elastase and its dramatic upregulation thus indicates that control of elastase activity is an important feature of the uterine infection. This notion is also supported by the strong upregulation of another elastase inhibitor, SKALP (24-fold). There was also a robust upregulation of MMP inhibitors, TIMP-1 and -2. In addition, a number of serine protease inhibitors of serpin type were induced. Out of these, plasminogen activator inhibitor 1 (PAI-1) showed the largest degree of upregulation and, notably, this was matched by a strong upregulation of the corresponding target, i.e. urokinase-type plasminogen activator.

SRGN, i.e. the gene coding for the core protein of serglycin proteoglycan, was one of the genes showing the largest extent of upregulation in diseased uteri. Serglycin has previously been shown to be critical for maintaining storage of secretory granule proteases in such cells [@pone.0008039-Pejler1] and the upregulated SRGN expression in diseased uteri may therefore be in line with the induction of proteolytic activities. Notably, mice lacking serglycin were previously shown to be more susceptible to *Klebsiella* infection than were wild type animals [@pone.0008039-Niemann1]. The present data thus support a prominent role for serglycin proteoglycan in host defense and also introduce the possibility to utilize serglycin as a biomarker for infection.

The massive downregulation of a number of homeobox and zinc finger genes during uterine infection is intriguing. Homeobox transcription factors have been widely implicated mainly in embryonal development and in cancer [@pone.0008039-Wensman1], [@pone.0008039-Christensen1] and the data presented here thus expand their repertoire of functions by implicating them in bacterial disease. Although we cannot with certainty explain why the homeobox genes are downregulated during disease, we may speculate that homeobox genes, during homeostatic conditions, have a role in suppressing pro-inflammatory pathways, and that downregulated expression of homeobox genes may unleash inflammatory cascades. In agreement with such a scenario, it has been shown that HOXA9 inhibits NF-κB-dependent activation of endothelium [@pone.0008039-Trivedi1] and that mice with a reduced expression of Cdx2 are hypersensitive to dextran sodium sulfate-induced acute inflammation [@pone.0008039-Calon1]. It is also of interest to note that a homeobox gene, TSHZ1 (teashirt), has previously been shown to inhibit caspase-4 gene expression [@pone.0008039-Kajiwara1]. Thus, the robust upregulation of caspase-4 in diseased animals ([Table 3](#pone-0008039-t003){ref-type="table"}) is clearly compatible with the decreased expression of homeobox factors. There is also evidence suggesting that certain zinc finger proteins may have a homeostatic function by repressing pro-inflammatory responses, including suppression of the NF-κB pathway [@pone.0008039-Hong1], [@pone.0008039-Moroy1]. Moreover, a recent study indicated that genes involved in zinc-related biology were downregulated during pediatric septic shock [@pone.0008039-Wong1].

An obvious extension of the present work will be to evaluate whether any of the identified upregulated genes can be utilized either as biomarkers for disease or as therapeutic targets. Moreover, it will be important to address whether the respective identified gene product is specifically associated with uterine bacterial infection or if its upregulation is a general consequence of bacterial insult. We believe that the results presented here may provide a basis for numerous future investigations where the usefulness of the candidate genes/gene products identified are evaluated in both canine and corresponding human disease.
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